1. Market Research
  2. > Biotechnology
  3. > Biopharmaceutical Market Trends
  4. > Blockbuster Biologics 2015: Sales of Recombinant Therapeutic Antibodies & Proteins

Blockbuster Biologics 2015: Sales of Recombinant Therapeutic Antibodies & Proteins


This report prepared by La Merie Publishing provides a compilation of the sales data of originator recombinant therapeutic proteins and antibodies in the calendar year 2015. Sales data were obtained from company publications and refer to branded products originating from companies based in regulated markets. All sales data were converted from their original, reported currency into US$ using official currency exchange rates as of March 9, 2016. Sales figures represent the sum of revenues in all territories where the products are marketed. Growth rates mosty are presented as reported (not based on constant exchange rates).


A total of 39 biologic therapeutics reached blockbuster status with 2015 sales exceeding US$ 1 bln: 21 antibodies and 18 proteins. Nine biologics reached global sales in 2015 of more than US$ 5 bln. Four biologics were new in the blockbuster biologics list and one dropped out. Six biopharmaceutical companies posted combined biologics sales of more than US$ 10 bln in the year 2015.


Sales data are presented for each product within the respective class of biologics. The data were analyzed to establish a ranking list of blockbuster biologics with 2015 sales higher than US$ 1 bln. Another ranking list was prepared for companies according to biologics sales in 2015 and the percentage of antibody sales of total biologics sales.


Table Of Contents

Blockbuster Biologics 2015: Sales of Recombinant Therapeutic Antibodies and Proteins

Blockbuster Biologics 2015: Sales of Recombinant Therapeutic Antibodies andamp; Proteins


Table of Contents


2015 Biologics Sales per Class of Products

Blockbuster Biologics in 2015 (by generic name)

Company Ranking List for Biologics Sales 2015

Biologic Product Sales 2015

•          Anti-TNF Antibodies

•          Cancer Antibodies

•          Insulin and Insulin Analogs

•          Other Anti-Inflammatory and Anti-Autoimmune Antibodies

•          Ophthalmic Antibodies

•          Recombinant Coagulation Factors

•          Erythropoietins

•          G-CSF

•          Interferon beta

•          Enzyme Replacement Proteins (ERT)

•          Cardiometabolic andamp; Anti-Infective Antibodies

•          Human Growth Hormone (hGH)

•          Follicle Stimulating Hormone (FSH)

•          Interferon alpha

•          Other Proteins: Cardiometabolic, Cancer andamp; Others


View This Report »

Get Industry Insights. Simply.

  • Latest reports & slideshows with insights from top research analysts
  • 24 Million searchable statistics with tables, figures & datasets
  • More than 10,000 trusted sources
24/7 Customer Support

Talk to Veronica

+1 718 514 2762

Purchase Reports From Reputable Market Research Publishers
PEGylated Proteins Market by Consumables, Services, Protein Type, Application, End-User - Global Forecast to 2021

PEGylated Proteins Market by Consumables, Services, Protein Type, Application, End-User - Global Forecast to 2021

  • $ 5650
  • Industry report
  • November 2016
  • by MarketsandMarkets

The global PEGylated proteins market is expected to USD 1,137.8 million by 2021 from USD 690.6 million in 2016, at a CAGR of 10.5% between 2016 and 2021. The growth of this market is mainly driven by increase ...

Protein Labeling Market by Product, Labeling Method, Application, & Region - Global Forecast to 2020

Protein Labeling Market by Product, Labeling Method, Application, & Region - Global Forecast to 2020

  • $ 5650
  • Industry report
  • December 2016
  • by MarketsandMarkets

The global protein labeling market is expected to reach USD 1,894.5 million by 2020 from USD 1,089.5 million in 2015, at a CAGR of 11.7% from 2015 to 2020. On the basis of products, the protein labeling ...

Remicade Biosimilar Market: By Type (Recombinant Non-Glycosylated Protein, Others), By Technology (MAb, rDNA, Others), By Service (Contract Research, CRAMS,Others), By Application (Blood Disorders, Oncology Diseases, Others), By Region-Forecast (2016-2021

Remicade Biosimilar Market: By Type (Recombinant Non-Glycosylated Protein, Others), By Technology (MAb, rDNA, Others), By Service (Contract Research, CRAMS,Others), By Application (Blood Disorders, Oncology Diseases, Others), By Region-Forecast (2016-2021

  • $ 5250
  • Industry report
  • September 2016
  • by Industry ARC

Globally, development of efficient and advance technology, higher expiration patent, rise in the awareness among people regarding remicade biosimilar, increasing government initiative across the globe, ...

Global Pea Protein Market

October 2016 $ 4250

Download Unlimited Documents from Trusted Public Sources

Protein Industry in the US

  • December 2016
    18 pages
  • Protein  

  • United States  

View report >

Influenza Statistics in the US

  • November 2016
    7 pages
  • Influenza  

    Influenza Vacci...  

    Vaccine  

  • United States  

View report >

The future of the Protein Industry in the Netherlands

  • November 2016
    8 pages
  • Protein  

    Food  

  • Netherlands  

View report >

Related Market Segments :

Protein

ref:plp2016

Reportlinker.com © Copyright 2016. All rights reserved.

ReportLinker simplifies how Analysts and Decision Makers get industry data for their business.